Superbio.AI Ltd 13918892 false 2022-02-16 2023-02-28 2023-02-28 The principal activity of the company is that of software publishing. Digita Accounts Production Advanced 6.30.9574.0 true 13918892 2022-02-16 2023-02-28 13918892 2023-02-28 13918892 bus:Director1 2023-02-28 13918892 bus:Director2 2023-02-28 13918892 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 13918892 bus:Micro-entities 2022-02-16 2023-02-28 13918892 bus:AuditExemptWithAccountantsReport 2022-02-16 2023-02-28 13918892 bus:FullAccounts 2022-02-16 2023-02-28 13918892 bus:SmallCompaniesRegimeForAccounts 2022-02-16 2023-02-28 13918892 bus:RegisteredOffice 2022-02-16 2023-02-28 13918892 bus:Director1 2022-02-16 2023-02-28 13918892 bus:Director2 2022-02-16 2023-02-28 13918892 bus:PrivateLimitedCompanyLtd 2022-02-16 2023-02-28 13918892 countries:EnglandWales 2022-02-16 2023-02-28 iso4217:GBP xbrli:pure

Registration number: 13918892

Superbio.AI Ltd

Annual Report and Unaudited Financial Statements

for the Period from 16 February 2022 to 28 February 2023

 

Superbio.AI Ltd

Contents

Company Information

1

Directors' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

4

 

Superbio.AI Ltd

Company Information

Directors

B Buyukkucak

R Nag

Registered office

30 Parkside Place
Parkside
Cambridge
CB1 1HQ

 

Superbio.AI Ltd

Directors' Report for the Period from 16 February 2022 to 28 February 2023

The directors present their report and the financial statements for the period from 16 February 2022 to 28 February 2023.

This report has been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

Incorporation

The company was incorporated on 16 February 2022.

Directors of the company

The directors who held office during the period were as follows:

B Buyukkucak (appointed 16 February 2022)

R Nag (appointed 16 May 2022)

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 13 February 2024 and signed on its behalf by:
 

.........................................
B Buyukkucak
Director

 

Superbio.AI Ltd

(Registration number: 13918892)
Balance Sheet as at 28 February 2023

2023
£

Current assets

3,680

Prepayments and accrued income

180

Creditors: Amounts falling due within one year

(355,006)

Total assets less current liabilities

(351,146)

Accruals and deferred income

(34,336)

 

(385,482)

Capital and reserves

(385,482)

 

Superbio.AI Ltd

(Registration number: 13918892)
Balance Sheet as at 28 February 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
30 Parkside Place
Parkside
Cambridge
CB1 1HQ

These financial statements were authorised for issue by the Board on 13 February 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 3.

For the financial period ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 13 February 2024 and signed on its behalf by:
 

.........................................
B Buyukkucak
Director